www.jurabio.com

A New Kind of CAR-T

AUTOIMMUNE DISEASES ARE ON THE RISE, AFFECTING THE LIVES OF MORE THAN 20 MILLION AMERICANS.

An autoimmune disease is triggered by the immune system turning against the body it is designed to protect from invading pathogens. Pathologic immune cells attack the body’s own tissue, triggering a cascade of events that cause damage to the targeted tissue.

Using the full potential of gene editing, JURA Bio is creating a novel therapeutic platform of cell-based therapies against autoimmune diseases that are both curative and definitive. We have developed a disruptive treatment approach that is harnessing the body’s immune system to neutralize pathologic cells. We are developing therapeutic cells engineered to bind to and kill pathologic immune cells.